1.Podracka L, Matousovic K: [Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis)]. Vnitr Lek 2013, 59(2):113–118.
2.Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H et al: Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. KIDNEY INT 2017, 91(5):1014–1021.
3.CM B, SK F, JT F, DC K, D B, AE C, SR D, de Ferranti SD, JM D, B F et al: Diagnosis, Evaluation, and Management of High Blood Pressure in Children and Adolescents. PEDIATRICS 2018, 142(3):undefined.
4.GJ S, MF S, PS M, M M, VR D, BA W, SL F, A M, The Chronic Kidney Disease In Children Study Is A Cohort Of About Children With Chronic Kidney Disease CKD In The United States And Canada. The Independent Variable For Our Observations Was A Measurement Of Glomerular Filtration Rate GFR By Iohexol Disappearance IGFR At The First Two Visits Year Apart And During Alternate Years Thereafter. In A Previous Report WHDG, However TCCO et al: Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. KIDNEY INT 2012, 82(4):445–453.
5.L S, M R, P C, de Souza V, J I, S L, F B, CE P, L D, BACKGROUND Estimating Kidney Glomerular Filtration Rate GFR Is Of Utmost Importance In Many Clinical Conditions. However VFSH et al: Comparison of the Schwartz and CKD-EPI Equations for Estimating Glomerular Filtration Rate in Children, Adolescents, and Adults: A Retrospective Cross-Sectional Study. PLOS MED 2016, 13(3):e1001979.
6.Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H et al: Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. KIDNEY INT 2017, 91(5):1014–1021.
7.AS L, de Jong PE, J C, M EN, BC A, K M, RT G, BL K, KU E, The Definition And Classification For Chronic Kidney Disease Was Proposed By The National Kidney Foundation Kidney Disease Outcomes Quality Initiative NKF-KDOQI In And Endorsed By The Kidney Disease Improving Global Outcomes KDIGO In This Framework Promoted Increased Attention To Chronic Kidney Disease In Clinical Practice RAPH: The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. KIDNEY INT 2011, 80(1):17–28.
8.E K, MJ S, R T, CE M, F L, M S, CY H, Background Our Objective Was To Explore The Effect Of Intensive Blood Pressure BP Control On Kidney And Death Outcomes Among Subgroups Of Patients With Chronic Kidney Disease Divided By Baseline Proteinuria GFRA, CI ATWP, CI ATWG et al: Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease. J AM HEART ASSOC 2019, 8(16):e12749.
9.L B, AS B, MJ C, LB H, C L, LH M, MJ S, H T, M W, Glomerulonephritis GN Is An Important Cause Of Morbidity And Mortality In Patients Of All Ages Throughout The World. Because These Disorders Are Relatively Rare IIDT: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. American journal of kidney diseases: the official journal of the National Kidney Foundation 2013, 62(3):403–441.
10.Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS: Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy. KIDNEY INT 2017, 91(1):235–243.
11.L Z, J L, S Y, N H, Q Z, Q Y, X Y, OBJECTIVE The Aim Of This Work Is To Investigate The Distinctive Clinicopathological Characteristics Of AKI In Chinese IgAN Population And Possible Risk Factors For AKI. MWPA: Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury. RENAL FAILURE 2016, 38(5):799–805.
12.H N, M M, CONTEXT IgA Nephropathy IgAN Is An Autoimmune Disorder And Is The Most Common Form Of Primary Glomerulonephritis GN Worldwide. EADO: Extracapillary proliferation in IgA nephropathy; recent findings and new ideas. Journal of nephropathology 2015, 4(1):1–5.
13.JC R, M H, HN R, IgA Nephropathy IgAN Is A Leading Cause Of CKD And Renal Failure. Recent International Collaborative Efforts Have Led To Important Discoveries That Have Improved Our Understanding Of Some Of The Key Steps Involved In The Immunopathogenesis Of IgAN. Furthermore EOMN: IgA Nephropathy. Clinical journal of the American Society of Nephrology: CJASN 2017, 12(4):677–686.
14.Lee H, Yi SH, Seo MS, Hyun JN, Jeon JS, Noh H, Han DC, Hwang SD, Jin SY, Kwon SH: Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults. KOREAN J INTERN MED 2012, 27(3):293–300.
15.Roufosse CA, Cook HT: Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 2009, 18(3):212–219.
16.Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V et al: Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. KIDNEY INT 2014, 86(4):828–836.
17.Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H et al: Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. KIDNEY INT 2017, 91(5):1014–1021.
18.Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, Cattran D, Cook HT, Coppo R, Feehally J et al: A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. J AM SOC NEPHROL 2017, 28(2):691–701.
19.Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H et al: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol 2011, 6(9):2175–2184.